HeartSmart

What HeartSmart does

HeartSmart, Inc. is a privately held US-based diagnostic services company headquartered in Newport Beach, California, providing the HeartSmart IMTplus cardiovascular screening service to physician practices. The company's core product uses B-mode carotid artery ultrasound to measure intima-media thickness (IMT) and identify plaque presence, composition, and vulnerability, enabling physicians to detect atherosclerosis at its earliest stages before heart attack or stroke. Scans are performed in-office by practice staff using existing or HeartSmart-arranged ultrasound equipment, with video uploads processed centrally by credentialed vascular technicians using frame-by-frame analysis. Results are returned as a color-coded Report Card that compares the patient's vascular status against a proprietary database of 40,000+ patients and over 1,000,000 data points stratified by age, gender, and ethnicity.

The underlying technology is described as the gold standard in IMT analysis, developed since 1997 by a leading IMT research authority and deployed commercially since March 2002 after initial use in pharmaceutical clinical trials and regulatory agency research. IMT testing is endorsed by the American Heart Association, American College of Cardiology, and American Society of Echocardiography, and is recommended by the SHAPE Task Force for screening men over 45 and women over 55. The service is delivered through HIPAA-compliant cloud infrastructure with SSL encryption and secure data handling.

HeartSmart operates a direct-to-physician-practice go-to-market model, providing turnkey implementation including equipment arrangement, installation, setup, and staff training so that practices do not require specialized personnel. Revenue is generated through diagnostic testing services on a quote-based pricing model that is not publicly disclosed, with additional private-labeling/white-labeling arrangements available for clients that want to incorporate their own branding on HeartSmart materials. The company has no disclosed external funding, no parent company, and a leadership team led by CEO Michael H. McCann.

Name

HeartSmart

Legal name

HeartSmart, Inc.

Website

https://heartsmartimt.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

HeartSmart, Inc. provides the HeartSmart IMTplus diagnostic service, using carotid ultrasound and a proprietary 40,000-patient database to detect early cardiovascular disease for physician practices across the United States.

Ownership category

akta.pro rank

Product category

Cardiovascular Diagnostic Services

NAICS

Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE)

akta.pro secondary industries

Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)

Keywords

• Cardiovascular diagnostic testing
• Carotid ultrasound screening
• Atherosclerosis detection
• Intima-media thickness analysis
• Vascular imaging services

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Testing Services: HeartSmart provides IMTplus cardiovascular screening services to physician practices. Physicians perform scans in-office (10-15 minutes) using existing or arranged ultrasound equipment, with scans uploaded for centralized analysis. The company generates revenue through the testing service provided to healthcare practices.
2. Licensing and White-Labeling: HeartSmart offers private labeling arrangements where clients (healthcare practices) can incorporate their own logos and address information on HeartSmart marketing and patient-oriented materials. The company provides these customized collaterals at direct cost to the client.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

HeartSmart provides IMTplus cardiovascular screening services to physician practices. Physicians perform 10–15 minute carotid B-mode ultrasound scans in-office using existing ultrasound equipment (or equipment arranged by HeartSmart), upload the scans via a HIPAA-compliant cloud platform, and receive centrally analyzed PDF reports comparing results against a proprietary 40,000+ patient database. The offering includes installation, setup, and staff training so practices can deliver the test without specialized personnel, plus a patient-facing Report Card for cardiovascular risk communication.

Product overview

HeartSmart offers a single unified diagnostic product, HeartSmart IMTplus, for early detection of cardiovascular disease through carotid artery ultrasound scanning. The core product is delivered as an in-office test performed by physicians, with scans uploaded to HeartSmart's centralized lab for frame-by-frame analysis and reporting. The companion HeartSmart IMTplus Report Card is the patient-facing output that translates scan results into a color-coded risk assessment, completing the diagnostic workflow from scan to patient communication.

Differentiator

Problem solved

Functional benefit

Products and services

• HeartSmart IMTplus A non-invasive, ultrasound-based cardiovascular diagnostic test that measures carotid intima-media thickness (IMT) using B-mode ultrasound scanning and centralized cloud-based analysis, sold to physician practices (primary care physicians, cardiologists, and other healthcare providers) for early detection of atherosclerosis in asymptomatic adult patients.
• HeartSmart IMTplus Report Card Patient-oriented cardiovascular health assessment report that grades individual risk from low to high (Categories A through E) by comparing scan results against HeartSmart's proprietary patient database categorized by age, gender, and ethnic background; designed to help adult patients immediately understand their cardiovascular health status and motivate compliance with physician recommendations.

Quantifiable outcome

• 78.5% correlation between patients with carotid plaque and coronary artery disease (CAD) in at least one coronary artery as validated by JACC study
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Endothelix: Endothelix develops and commercializes automated Carotid Intima-Media Thickness (CIMT) measurement technology (Velas/Infinity IMT), directly competing with HeartSmart IMTplus in the same clinical niche of non-invasive cardiovascular imaging.
• CardioHealth (Panasonic): CardioHealth Station is a carotid ultrasound-based cardiovascular screening device, providing automated IMT measurement in physician offices as a direct alternative to HeartSmart IMTplus for early CVD risk assessment.

Broad incumbents

• Philips Healthcare: Philips is a major incumbent in cardiac ultrasound and imaging informatics, with carotid imaging capabilities that physicians could use as alternatives to HeartSmart's centralized IMTplus analysis service.
• Siemens Healthineers: Siemens is a global incumbent in cardiovascular imaging, offering ultrasound, CT, and MRI systems that physicians can use to perform carotid IMT and broader cardiac imaging, competing with HeartSmart at the equipment layer.
• GE HealthCare: GE HealthCare provides ultrasound systems, CT scanners, and cardiac imaging software that physicians use for cardiovascular screening, including IMT-capable ultrasound platforms that overlap with HeartSmart's clinical workflow.
• Quest Diagnostics: Quest Diagnostics is a large national clinical laboratory that offers cardiovascular risk panels and the former Cleveland HeartLab cardiometabolic diagnostics, representing a competing route for physicians seeking cardiovascular prevention testing.

Emerging players

• Medis Medical Imaging: Medis provides quantitative cardiac and vascular imaging software, including IMT analysis tools integrated into PACS, which competes with HeartSmart's proprietary analysis layer for carotid IMT reporting.
• AtheroPoint: AtheroPoint develops AI-based cardiovascular imaging analytics, including CIMT and carotid plaque characterization, directly competing with HeartSmart's image-analysis capabilities through an emerging AI-driven approach.
• HealthECCO: HealthECCO provides cloud-based cardiac imaging analysis services including echocardiography and vascular imaging, overlapping with HeartSmart's centralized-analysis, cloud-delivered diagnostic model.
• AmCAD Biomed: AmCAD Biomed offers ultrasound-based quantitative imaging analysis software, including cardiovascular applications such as IMT and plaque analysis, positioning it as a technology peer to HeartSmart's image-analysis service.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/heartsmart-inc.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeartSmart